Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Allogene Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · South San Francisco, CA, United States

  1. PrincipalsBenjamin Machinas BeneskiSVP, Chief Technical OfficerDavid D ChangPresident and CEOGeoffrey M. ParkerCHIEF FINANCIAL OFFICERand 5 more
  2. CompanyAllogene Therapeutics, Inc.South San Francisco, CA, United States
  3. Phone line+1 (650) 457-2700General business
Request a quote

Allogene Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker ALLO) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 8

Chief executive

David D ChangPresident and CEO

Chair & board

Arie BelldegrunDirector (Board)
Joshua A KazamDirector (Board)

Finance

Geoffrey M. ParkerCHIEF FINANCIAL OFFICER

Technology & engineering

Benjamin Machinas BeneskiSVP, Chief Technical Officer
Zachary RobertsEVP of R&D

Legal

Earl Martin DouglasSVP, General Counsel
Everyone else on file (1)
Annie YoshiyamaSVP, Finance

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. David D Chang — President and CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Benjamin Machinas Beneski — SVP, Chief Technical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Geoffrey M. Parker — CHIEF FINANCIAL OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers